Table 3.
The χ2 statistic on Disease-Specific Survival and Progression-Free Survival for Anatomic and Prognostic Stage of TNBCs included in SYSUCC-PWH cohort (N = 611)
| Stage | Disease-Specific Survival | Progression-Free Survival | ||||||
|---|---|---|---|---|---|---|---|---|
| AS | PS | AS | PS | |||||
| χ2 | p-value | χ2 | p-value | χ2 | p-value | χ2 | p-value | |
| Ia vs IIA | 0.5876 | 0.4433 | 0.5876 | 0.4433 | 0.006753 | 0.9345 | 0.0068 | 0.9345 |
| IIA vs IIB | 3.214 | 0.073 | 1.572 | 0.2099 | 10.36 | 0.0013 | 10.05 | 0.0015 |
| IIB vs IIIA | 2.16 | 0.1417 | 0.0016 | 0.9681 | 5.765 | 0.0163 | 0.6587 | 0.417 |
| IIIA vs IIIB | 4.204 | 0.0403 | 1.239 | 0.2656 | 0.5332 | 0.4653 | 0.7811 | 0.3768 |
| IIIB vs IIIC | 0.2007 | 0.6541 | 0.7913 | 0.3737 | 1.922 | 0.1656 | 2.294 | 0.1299 |
aNo case was classified as anatomic stage IB in this cohort
TNBC triple negative breast cancer, AS anatomic stage, PS prognosis stage